KEROS THERAPEUTICS IN
58.55
27-11月-24 16:45:00
15 分の遅延
株式
+1.16
+2.02%
本日の幅
56.78 - 58.81
ISIN
N/A
ソース
NASDAQ
-
Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
03 1 2024 21:29:25 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Proposed Public Offering of Common Stock
03 1 2024 16:05:39 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Develop KER-065 for the Treatment of Obesity
03 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
11 12 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Upcoming Healthcare Conferences
07 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
06 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
02 11 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Upcoming Healthcare Conferences
05 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
07 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
12 6 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
07 6 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
22 5 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association
11 5 2023 16:01:01 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
04 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors
19 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
03 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
01 3 2023 08:00:02 提供 Nasdaq GlobeNewswire